FOIA Number: VA-19-1108

News Roundup: Trump’s Enthusiastic Support for New Drug Raises Questions

September 6, 2019
Investigating the administration's approval of Spravato, Trump's potential campaign-finance violations, and the promotion of Trump properties.
(Photo: Gage Skidmore)

FOIA to VA Seeking Email Communications Between VA Officials and Spravato Manufacturers

September 4, 2019
FOIA request to the Department of Veterans Affairs seeking email communications between VA officials, Janssen, and Johnson & Johnson executives regarding the anti-depressant nasal spray Spravato (esketamine).